rs2922126 — GHSR GHSR A/G (rs2922126)

Upstream regulatory variant near the ghrelin receptor gene; the A allele is associated with abdominal adiposity and metabolic syndrome risk in women through altered GHSR expression

See your personal result for GHSR

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Hunger Hormone's Receptor: When GHSR Expression Tips the Balance

Every time your stomach empties, it sends a chemical distress signal — a 28-amino-acid peptide called ghrelin — up the bloodstream and into the brain. Ghrelin11 Ghrelin
The "hunger hormone," secreted primarily by the stomach fundus before meals and suppressed after eating. Rises during caloric restriction and after weight loss. docks onto its receptor, GHSR-1a (growth hormone secretagogue receptor type 1a), triggering appetite and promoting fat storage. But ghrelin does far more than tell you it's time to eat. GHSR-1a is also expressed in the brain's mesolimbic reward circuit22 mesolimbic reward circuit
Dopaminergic pathways connecting the ventral tegmental area to the nucleus accumbens, mediating motivation and pleasure responses to food, drugs, and other rewards., where it amplifies the desirability of food and drives motivated eating beyond simple caloric need. rs2922126 sits roughly 2 kilobases upstream of GHSR and influences the regulatory region that controls how much receptor is produced.

The Mechanism

rs2922126 is an upstream regulatory variant33 upstream regulatory variant
Located ~2 kb before the GHSR transcription start site, within the promoter/proximal regulatory region that controls GHSR gene expression. — not a coding change, so the ghrelin receptor protein sequence is identical in all genotypes. The A allele is thought to alter transcription factor binding at the GHSR promoter, potentially shifting baseline receptor expression levels. Higher GHSR expression would amplify ghrelin signaling: stronger pre-meal hunger signals, increased food-reward sensitivity, and enhanced fat storage signaling. Nearby GHSR promoter variants with better-characterized function — particularly rs490683, which disrupts a nuclear factor 1 (NF-1) binding site — show that altered transcription factor access at this promoter44 altered transcription factor access at this promoter
Mager et al. 2008 demonstrated that the rs490683-GG genotype with an intact NF-1 site shows increased GHSR promoter activity in reporter assays. has measurable metabolic consequences. rs2922126 likely operates through a similar mechanism, though its specific transcriptional effect has not been directly characterized.

The Evidence

The primary evidence for rs2922126 comes from a 2008 case-control study by Li et al.55 Li et al.
Ghrelin receptor gene polymorphisms are associated with female metabolic syndrome in Chinese population. Chinese Medical Journal, 2008. enrolling 698 metabolic syndrome patients and 762 controls in China (total N=1,460). In women, the A/A genotype was associated with metabolic syndrome (OR 1.41, 95% CI 1.03–1.94), increased waist circumference (OR 1.75, 95% CI 1.26–2.42), and elevated fasting blood glucose (OR 1.49, 95% CI 1.07–2.06). These associations were not observed in men, pointing to a sex-hormone-mediated interaction between ghrelin signaling and central adiposity.

A 2013 prospective study by Yan et al.66 Yan et al.
Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a PRoBE design approach. SpringerPlus, 2013. (180 cases, 732 controls) found that A/A homozygotes had a protective association against post-menopausal breast cancer (OR 0.4, 95% CI 0.18–0.89, p=0.02). This finding may reflect ghrelin's complex relationship with adipose tissue and estrogen signaling in post-menopausal women, though replication is needed before clinical weight is assigned to this result.

Null results also inform the picture. A longitudinal study of 1,362 children Riedl et al.77 Riedl et al.
GH secretagogue receptor gene polymorphisms are associated with stature throughout childhood. European Journal of Endocrinology, 2012. found no association between rs2922126 and height or BMI across a 10-year follow-up, and a 2021 case-control study Tabaeian et al.88 Tabaeian et al.
NAFLD case-control study, N=310. Journal of Gastrointestinal and Liver Diseases, 2021. found no association with non-alcoholic fatty liver disease. A systematic review Ghalandari et al.99 Ghalandari et al.
Review of 24 GHRL/GHSR case-control studies. Int J Endocrinol Metab, 2015. concluded that the overall evidence across GHRL/GHSR polymorphisms and obesity is inconclusive. The metabolic syndrome signal from Li et al. has not been widely replicated in European or African ancestry populations.

Practical Actions

The A allele's primary actionable signal is elevated abdominal adiposity risk in women, mediated through amplified ghrelin/GHSR appetite signaling. Because GHSR drives hunger at the pre-meal level and amplifies food reward signals, targeted strategies that blunt pre-meal ghrelin spikes — rather than generic caloric restriction — are most aligned with the mechanism. High-protein meals are particularly effective at suppressing ghrelin compared to carbohydrate-matched meals, and distributing protein intake across three meals (rather than concentrating it at dinner) gives the most sustained pre-meal ghrelin suppression. For women with A/A genotype, waist circumference and fasting glucose are the most relevant biomarkers to track given the Li et al. findings.

Interactions

GHSR promoter variants rs490683 and rs9819506, studied by Mager et al. 2008 in the Finnish Diabetes Prevention Study, showed associations with body weight and glucose metabolism respectively. rs490683 has direct functional evidence (NF-1 binding site disruption) and may compound with rs2922126 if both variants shift GHSR expression in the same direction. rs572169, studied by Gueorguiev et al. 2009, was associated with obesity (OR 1.73, p=0.007) in an additive model — this is a distinct GHSR variant whose interaction with rs2922126 has not been studied. All four variants are within or near the GHSR promoter/upstream region and may tag related regulatory haplotypes.

Genotype Interpretations

What each possible genotype means for this variant.

TT Common Genotype Normal

Reference genotype — typical ghrelin receptor expression and appetite signaling

You carry two copies of the T allele, the reference sequence at this upstream GHSR position. Globally, approximately 52% of people share this genotype; in Europeans the frequency is slightly lower as the A allele is more common there (~37% A allele frequency). There is no documented elevated risk from this genotype — your ghrelin receptor expression at this locus follows the common regulatory pattern.

AT One A Allele Intermediate

One copy of the GHSR upstream A allele — modestly elevated appetite signaling risk

The A allele sits in the GHSR promoter region and may alter transcription factor binding, shifting baseline ghrelin receptor expression. For women with AT genotype, the metabolic syndrome association (OR 1.41 in A/A women from Li et al. 2008) likely represents a ceiling estimate; AT carriers would be expected to show a smaller effect under an additive model. The sex-specific nature of the finding in the Li et al. cohort suggests estrogen-dependent modulation of ghrelin receptor signaling — post-menopausal women or those with hormonal changes may be more sensitive to this variant's effects.

AA Two A Alleles High Risk

Two copies of the GHSR upstream A allele — elevated abdominal adiposity and metabolic syndrome risk in women

The A/A genotype represents full homozygosity at the GHSR upstream regulatory position, with both alleles potentially shifting promoter activity compared to the reference T allele. Under an additive model, homozygotes carry twice the allele dosage of heterozygotes. The Li et al. 2008 sex-specific findings are biologically plausible: estrogen upregulates GHSR expression in the hypothalamus, and if the A allele further amplifies this upregulation, the combined effect on appetite signaling could be substantially larger in women than men. The elevated waist circumference association (OR 1.75) is noteworthy because central adiposity is a metabolic syndrome criterion that GHSR-driven fat storage (preferentially visceral in response to ghrelin) could directly influence. A separate prospective study (Yan et al. 2013) found that A/A women had a lower risk of post-menopausal breast cancer (OR 0.4), which may reflect ghrelin's complex relationship with adipose-tissue estrogen production — this does not negate the metabolic risk finding and should not be interpreted as a reason to view A/A as broadly protective in women.